Published in Lab Business Week, January 21st, 2007
Among the findings: Attention Deficit Hyperactivity Disorder (ADHD) is now the 9th largest segment of the central nervous system (CNS) market by sales with growth of 8% year-on-year.
The value of the ADHD market was $2.6 billion in 2005. Global sales of ADHD drugs are forecast to reach $4.3 billion by 2012. This will be due to greater penetration in the treatment of new patients, particularly adult ADHD, improvements in patient compliance due to the launch of new formulations, new...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.